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Predictors of human immunodeficiency
virus (HIV) infection in primary care among
adults living in developed countries: a
systematic review
Benhildah N. Rumbwere Dube1*, Tom P. Marshall1, Ronan P. Ryan1 and Modupe Omonijo2
Abstract
Background: Early diagnosis of human immunodeficiency virus (HIV) is important because antiretroviral therapies are
more effective if infected individuals are diagnosed early. Diagnosis of HIV relies on laboratory testing and determining
the demographic and clinical characteristics of undiagnosed HIV-infected patients may be useful in identifying patients
for testing. This systematic review aims to identify characteristics of HIV-infected adults prior to diagnosis that could be
used in a prediction model for early detection of patients for HIV testing in UK primary care.
Methods: The population of interest was adults aged ≥ 18 years in developed countries. The exposures were
demographic, socio-economic or clinical characteristics associated with the outcome, laboratory confirmed HIV/
AIDS infection. Observational studies with a comparator group were included in the systematic review. Electronic
searches for articles from January 1995 to April 2016 were conducted on online databases of EMBASE, MEDLINE,
The Cochrane Library and grey literature. Two reviewers selected studies for inclusion. A checklist was developed
for quality assessment, and a data extraction form was created to collate data from selected studies.
Results: Full-text screening of 429 articles identified 17 cohort and case-control studies, from 26,819 retrieved
articles. Demographic and socio-economic characteristics associated with HIV infection included age, gender and
measures of deprivation. Lifestyle choices identified were drug use, binge-drinking, number of lifetime partners
and having a partner with risky behaviour. Eighteen clinical features and comorbid conditions identified in this
systematic review are included in the 51 conditions listed in the British HIV Association guidelines. Additional
clinical features and comorbid conditions identified but not specified in the guidelines included hyperlipidemia,
hypertension, minor trauma and diabetes.
Conclusion: This systematic review consolidates existing scientific evidence on characteristics of HIV-infected
individuals that could be used to inform decision making in prognostic model development. Further exploration of
availability of some of the demographic and behavioural predictors of HIV, such as ethnicity, number of lifetime partners
and partner characteristics, in primary care records will be required to determine whether they can be applied in the
prediction model.
Keywords: Acquired immuno-deficiency syndrome, Antiretroviral therapies, Diagnosis, Human immunodeficiency virus,
Patient characteristics, HIV predictors, Primary care
* Correspondence: bnr546@bham.ac.uk
1Institute of Applied Health Research, University of Birmingham, Birmingham
B15 2TT, UK
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Rumbwere Dube et al. Systematic Reviews  (2018) 7:82 
https://doi.org/10.1186/s13643-018-0744-3
Background
Human immunodeficiency virus (HIV) is a retroviral
infection that weakens the immune system and is a subse-
quent causative agent of acquired immuno-deficiency
syndrome (AIDS) [1, 2]. The virus is transmitted through
the exchange of a variety of bodily fluids mainly sexually,
perinatal and blood-borne [2, 3]. HIV/AIDS is one of the
highest contributors to morbidity and the sixth leading
cause of mortality worldwide [2, 4]. The World Health
Organization (WHO) estimated that 1.5 million people
died of HIV/AIDS-related diseases and 36.7 million lived
with HIV worldwide, in 2015 [5]. In 2015, it was estimated
that 594 deaths were associated with HIV\AIDS in England
and 101,200 people were estimated to live with HIV in
the UK [6].
The life expectancy of HIV-infected individuals has
increased over the years and is approaching that for the
general population [7, 8]. This is a result of the effectiveness
of antiretroviral therapies (ART) that has led to most indi-
viduals coping with HIV infection as a chronic condition
rather than an illness inevitably leading to death [9]. The
use of ARTs has led to a better quality of life for infected
individuals and a reduction in morbidity and mortality [4].
In the 1980s/1990s, more focus was placed on HIV
prevention strategies and treatment of symptomatic
diseases but due to the benefits of ART, the emphasis
has now moved to earlier HIV diagnosis [10]. WHO
developed a strategy aimed at reducing new HIV infections,
AIDS-related mortality and discrimination to zero with
one of the HIV strategies being optimisation of ‘HIV pre-
vention, diagnosis, treatment and care outcomes’ [11].
The CD4 count is an indicator of immunosuppression
in an individual infected with HIV [9]. Early diagnosis of
people with HIV (cluster of differentiation 4 (CD4) >
350/mm3) improves the effectiveness of antiretroviral
therapies, and additionally, the treatment and advice
provided reduces onward transmission, thereby making
late diagnosis of HIV (CD4 < 350/mm3) an important
public health concern [12, 13]. Furthermore, early diagnosis
of HIV and earlier use of therapies reduce health and social
care costs by preventing illness associated with HIV [4, 14].
On the other hand, delayed diagnosis of HIV to late stages
(CD4 < 350/mm3) leads to worse prognosis for the patient
due to irreversible immunologic damage and associated
problems [13, 15].
Public Health England estimated that out of the 101,200
individuals living with HIV in 2015, 6095 were newly diag-
nosed and 13% were unaware of their HIV status [6]. In
that year, 39% of people that were newly diagnosed with
HIV in the UK were detected late (CD4 < 350/mm3), which
is an intolerably high proportion [6]. Meanwhile, evidence
shows that about 33% of patients that are diagnosed with
HIV in the UK would have seen a general practitioner
(GP) within the previous year [9, 16, 17]. One study found
that one in three patients that presented at least one
HIV-related symptoms to their GPs was consequently
diagnosed with HIV by their GP [18]. Therefore, primary
care has a role to play in increasing uptake of HIV
diagnostic testing since nearly all the UK population is
registered with a GP [19]. HIV testing in general practices
can be done by either sending blood samples for laboratory
testing or conducting combined HIV antibody and protein
24 (P24) antigen tests followed by laboratory confirmation
[9]. However, among those who visit their GP, a challenge
is the fact that HIV/AIDS has many signs and symptoms
such as rashes, weight loss and respiratory infections and
these are not specific to HIV/AIDS.
Current UK guidelines from British HIV Association
(BHIVA) recommend HIV testing to individuals from
high-risk groups, those with symptoms indicative of HIV
or where HIV forms part of the diagnosis [20]. However,
approximately three-quarters of patients consult their
GPs in the period prior to diagnosis may not present these
indicator symptoms and diagnoses [17]. This suggests that
these currently recommended predictive factors are of
limited use in the identification of possible HIV-infected
individuals.
The methods used in routine HIV testing either involve
use of screening assays on blood for laboratory testing or
rapid tests conducted on samples from a finger-prick or
mouth swab at point of care. The commonly used and
recommended first-line assays test for HIV antibodies and
the HIV p24 antigens simultaneously [9, 20]. These assays
can be utilised within a month of HIV infection [9, 20].
The sensitivity of these assay tests ranges from 99.8–100%
and the specificity ranges from 99.4–100% [21, 22].
Point-of-care tests (POCTs) are rapid testing devices that
diagnose HIV within 15 min. However, such tests have
lower specificity in comparison to laboratory tests, thereby
giving significantly high proportion of false positives,
especially when used in low prevalence settings [9]. It is
therefore possible to test for and diagnose HIV using
simple blood tests with few false positives and false
negatives.
The UK primary care clinicians need to identify patients
who should be offered HIV testing. A systematic review is
therefore necessary to identify demographic, lifestyle,
clinical and laboratory characteristics of patients which
might be associated with HIV infection in primary care.
The identified characteristics will be investigated to deter-
mine if they are documented in electronic primary care
records and whether they can be used to predict which
primary care patients are likely to have HIV infection.
This systematic review identifies, critically evaluates and
interprets available evidence related to the demographic,
lifestyle, clinical and laboratory characteristics associated
with HIV/AIDS infection in adults in the developed
world [23, 24].
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Methods
This systematic review conforms to the requirements of
the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (Additional file 1, PRISMA) [25]. The
methods were detailed in a published protocol, but a
summary is included in this section [26]. The PROSPERO
registration number for the protocol is CRD42016042427.
Review question
This systematic review systematically identifies and
summarises evidence on characteristics of HIV-infected
adults which could be used in a prediction model for
early detection of HIV in primary care.
The review question is:
What demographic, lifestyle, clinical and laboratory
characteristics are associated with HIV infection in adults
aged 18 years and over?
Population, exposure and outcome
Studies selected included human participants ≥ 18 years.
Exposures may be demographic, socio-economic or
clinical risk factors or characteristics associated with
HIV infection. The comparison group is either people
without risk factors or no comparison group. The out-
come is laboratory-confirmed HIV/AIDS infection.
Study design
This review considers observational (analytical) studies,
comparing groups and produces predictive values or
likelihood ratios (case-control and cohort, both retro-
spective and prospective studies) [27].
Search strategy
Studies are identified via electronic searches of EMBASE
(Ovid), MEDLINE (Ovid), The Cochrane Library (Wiley)
and the unpublished grey literature (SIGLE, Google
Scholar and BASE). Additional searches are conducted
on abstracts or conference proceedings using Web of
Science Conference Proceedings Citation Index (CPCI),
Global Index Medicus, guidelines (NICE, DH) and reference
searching [28]. There were no language restrictions, and all
studies published from year 1995 to April 2016 were
included. The search terms used in Ovid MEDLINE
(Additional file 2: Appendix I) are adjusted to suit
searches in other databases. References were searched
and stored using the Refworks referencing programme.
Inclusion/exclusion criteria
To ensure generalisability to a UK setting, only studies
undertaken in the following developed countries are
included in this review: Europe (all countries) and North
America (USA and Canada), Australia and New Zealand.
Studies which include children only are excluded.
Selection procedure
Two reviewers independently selected articles in the first
and second screening of articles. The first screening
checked titles/abstracts to find out if articles addressed
the review question and fulfilled the inclusion and exclu-
sion criteria (Additional file 3: Appendix II). The second
screening was the full article review. Differences between
the reviewers were resolved through discussions.
Quality assessment and data extraction
Quality assessment was done using a checklist for
cohort and case-control studies modified from the Scottish
Intercollegiate Guidelines Network (SIGN) [29].
A data extraction form was developed to collate data
from selected articles. Tabulation and narrative of the
results were produced, and the tabulation contains
description of the articles (the author, publication year,
the study design, number of participants, population
under study and outcome).
Results
Selection procedure
A total of 26,819 hits were returned from the database
searches and NICE and DH, 6173 duplicates were
removed and 20,646 articles were pre-screened (Fig. 1).
The first review resulted in selection of 429 articles
using titles/abstracts. A discussion was held to agree on
the articles selected. The reviewers independently selected
suitable articles using full text and a second discussion
was held. The reviewers agreed on 17 articles: 11 cohort
and 6 case-control studies.
Quality of studies
All 11 cohort studies were of acceptable standard, but
only 2 were of high quality, in terms of participant
recruitment, sample size and how they dealt with bias.
The other articles were not clear about how they dealt
with confounding factors (Table 1). All 6 case-control
studies were of acceptable standard, and half of them
were of high quality, in terms of participant recruitment,
sample size and how they dealt with bias.
Study characteristics
The cohort studies were conducted in the UK (3),
Ireland (1), Australia (1) and USA (6). The number of
participants ranged from 32 to over 20,000 with most
studies focusing on patients aged ≥ 18 years. The study
duration ranged from 1 to 5 years, but some of the studies
did not state follow-up intervals (Table 1).
The case-control studies were conducted in the UK
(1), Netherlands (1), the USA (2) and Canada (2). In
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total, they included 1412 cases and 3423 controls. The
study duration ranged from 1 to 12 years with a 6-month
follow-up for most of the studies.
Identified predictors of HIV infection
The predictors of HIV identified were categorised into
demographic and socio-economic, behavioural or life-
style, clinical features and comorbidities. Statistically
significant characteristics or those with highest percentages
were included.
Demography and socio-economic
The significant demographic characteristics (Table 2)
associated with HIV infection were (i) homosexuals and/or
bisexuals, mainly men who have sex with men (MSM)
(5 studies) 1.8 to 2.7 times risk [30–34], (ii) black ethnicity
(1 study); 6.8 times risk [30] and (iii) age ranges (3 studies),
mainly between 27 and 40 years with up to 11.5 times the
risk [31, 35, 36]. Two studies revealed that gender had no
significant association with the risk of HIV infection
[30, 31]. Two studies showed conflicting evidence on
the increased risk of HIV infection associated with
country of birth; one study from the USA showed that
being born in the USA was associated with 1.76 times
the risk [30], but a study from Australia showed that
being born in Australia had a non-significant risk [35].
Socio-economic conditions associated with increased risk
of HIV identified were (i) poverty in urban but not in rural
areas (1 study) [37], (ii) annual income under $10,000 having
13 times the risk (1 study) [30], (iii) unemployment (1 study)
[30], (iv) housing problems (1 study) [30] and (v) not being
a high school graduate or having low education attainment
(2 studies); 2.2 times the risk [30, 38].
Behavioural characteristics
Behavioural characteristics (Table 3) associated with an
increased risk of HIV infection can be categorised into
personal lifestyle, partner lifestyle and effects of life events.
Fig. 1 PRISMA 2009 flow diagram
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Personal lifestyle choices identified were (i) injecting drugs
(7 studies); 2 to 21 times the risk [30, 31] [32–36], (ii)
smoking crack cocaine (1 study); 22.8 times the risk
[30], (iii) being a current smoker (1 study) [38], (iv)
binge-drinking (1 study); 12.8 times the risk [34], (v)
exchanging money or drugs for sex (1 study); 19 times
the risk [30], (vi) male anal sex (1 study); 1.6 times the
risk [35] and (vii) being obese (1 study) [30]. Personal
sexual behaviours identified were unsafe sex (2 studies);
1.8 times the risk [35, 38] and having multiple sex partners
(1 study); 5.5 times the risk for males with ≥ 10 and 20
times the risk for females with ≥ 3 lifetime partners [30].
Partner-related behaviours identified were (i) HIV-positive
partner (2 studies); 3 and 8 times the risk [35, 36], (ii)
partner’s use of illicit drugs (2 studies); 1.57 and 17 times
[30, 36], (iii) partner’s alcohol dependence/binge-drinking
(1 study); 1.4 to 1.8 times the risk [39].
One study revealed risk-associated stressful events in
men having sex with men to be; (i) the number of stressful
events, (ii) events occur in ages under 30 years associated
with 7 times the risk, (iii) type of stressful events such as
bereavement and death of close friend and financial crisis
and relationship breakdown (romantic and other relations);
3 times the risk [40].
Clinical features
Evidence from 4 studies (Table 4) revealed that HIV
infection was associated with clinical features: (i) flu-like
symptoms including fever/chills and cough (3 studies); 4.5
times the risk [33, 39, 41], (ii) rash (1 study); 4.5 times the
risk [39], (iii) weight loss (2 studies); 13 to 39 times the
risk [17, 41], (iv) diarrhoea (2 studies); 2 to 4.4 times
the risk [17, 41] and one study identified abdominal
pain, minor trauma and nausea/vomiting as the condition
affecting 5–6% of the HIV-positive patients [33].
Comorbidities associated with HIV
The clinical indicator conditions (Table 4) were categorised
into the following: respiratory, dermatology, neurology,
gastroenterology, gynaecology, haematology, ophthalmology,
ear, nose and throat (ENT) and other (not classified).
The respiratory conditions identified were pneumonia
(2 studies); 8 and 48 times the risk [17, 41] and pneumo-
cystis in 52% of the HIV-infected patients (1 study) [42].
The dermatological conditions identified were psoriasis
(2 studies); 2.6 to 3 times the risk [17, 41] and herpes
zoster (2 studies); 10.9 and 25.4 times the risk [17, 41].
The evidence revealed that HIV infection was signifi-
cantly associated with peripheral neuropathy (1 study);
15.9 times the risk [41] and neurologic disabilities cranial
nerve abnormalities and fine limb movement (1 study);
2.4 times the risk in women and 1.9 times the risk in men
[43]. The gastroenterological conditions identified were
oral candidiasis (2 studies); 7.1 and 29.4 times the risk
[17, 41], hepatitis B (2 studies); 8.3 and 11.5 times the
risk [44, 41] and liver diseases (1 study), affecting 22%
Table 3 Behavioural or lifestyle––personal choices identified in selected studies
Predictor Ellerbrock
2004 [30]
Gordon
1995 [32]
Guy 2011 [35] Hafner
1997 [33]
Hodder
2013 [36]
Moran
2012 [34]
Ross
1997 [31]
Desai
2012 [38]
Szerlip
2005 [39]
OR % OR % OR % OR % OR
Injected drugs users 21.1 (4.89–90.9) 18% 2.97 (1.77–5.00) 30% 2.71 (1.33–5.53) 10% 2.3 (1.5–3.5)
Ever smoked crack
cocaine
22.8 (12.6–41.5)
Binge-drinking or
alcohol misuse
1.57* (0.74–3.33) 12.8 (1.65–99)
Substance use
(combined)**
2.52 (1.22–5.21) 22%
Current smokers 25%
Unsafe sex 1.84 (1.6– 3.20) 60%
HIV positive partner 3.24 (1.47–7.11)
Sex with drug user 17.2 (7.18–40.9)
Contact abroad 2*
Ever exchanged money
or drugs for sex
19.3 (11.2–33.2)
Male anal sex in the last
≥ 6 months
1.63 (1.13– 2.35)
Multiple life partners M: 5.51 (3.18–9.55)
F: 19.8 (8.81–44.2)
Obesity 10%
*Not statistically significant
**Includes drug use or binge-drinking
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Table 5 Predictors identified and availability in electronic primary care records
Category of predictor Predictor of HIV infection Likelihood of being recorded in primary care records
Sociodemographic Age Present for all patients
Gender Present for all patients
Social status Inferred from postcode
Poverty index Present as deprivation quintile
Annual income Inferred from prescription payments, benefits
Employment status Likely to be poorly recorded
Sexual orientation Require further investigation
Not a high school graduate Not present
Country of birth Not present
Ethnicity Present for some patients
Behavioural Smoking status Very likely to be present
Drug use Present for some patients
Binge-drinking or alcohol misuse Present for some patients
Obesity Very likely to be present
Contact abroad Might be present
Stressful events Present for some patients
Unsafe sex Likely not present
Ever exchanged money or drugs for sex Likely not present
Male anal sex Likely not present
Number of lifetime partners Likely not present
Partner characteristics Likely not present
Clinical and comorbid conditions Weight loss Likely to be present
Fever or chills Likely to be present
Cough Likely to be present
Flu like symptoms Likely to be present
Diarrhoea Likely to be present
Abdominal pain Likely to be present
Minor trauma Likely to be present
Nausea/vomiting Likely to be present
Rash Likely to be present
Pneumonia Likely to be present
Pneumocystis carinii Likely to be present
Psoriasis Likely to be present
Herpes zoster Likely to be present
Peripheral neuropathy Likely to be present
Neurologic disability Likely to be present
Oral candidiasis Likely to be present
Hepatitis B Likely to be present
Chronic liver disease Likely to be present
Non-Hodgkin’s lymphoma Likely to be present
Condyloma acuminata Likely to be present
Leucocytopenia Likely to be present
Blood dyscrasia Likely to be present
Lymphadenopathy Likely to be present
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of the HIV-infected patients [45]. One oncological condi-
tions identified was Non-Hodgkin’s lymphoma (1 study);
12.6 times the risk [17].
Only one study identified gynaecological conditions
associated with increased risk of HIV diagnosis and
condyloma acuminata; 12.1 times the risk [41]. The two
haematological conditions identified in the studies were
leukocytopenia (1 study); 11.5 times the risk [41] and
blood dyscrasia (1 study); 5.7 times the risk [17]. ENT
conditions identified were lymphadenopathy (2 studies);
11.3 and 29.8 times the risk [17, 41] and parotitis (1 study);
8.6 times the risk [17].
The other conditions identified were mononucleosis-like
illness (1 study); 6.2 times the risk [41], pyrexia of unknown
origin (1 study); 7.2 times the risk [17] and one study which
had 10–25% of the HIV-infected patients with hyperlipid-
emia, hypertension and diabetes [45]. The other conditions
identified were sexually transmitted infections (5 studies),
2.7 to 37.9 times the risk [17, 30, 35, 44, 41], and the
following infections were identified: (i) syphilis (3 studies),
3.9 to 39.3 times the risk [30, 44, 41]; (ii) chlamydia (2
studies), 2.3 to 11.8 times the risk [30, 35]; (iii) gonorrhoea
(2 studies), 6.5 to 15.9 times the risk [30, 41] and (iv)
genital herpes (1 study), 2.9 times the risk [41].
Discussion
This systematic review identified 10 demographic and
socio-economic characteristics, 11 behavioural character-
istics, and 27 clinical features and comorbid conditions
that are significantly associated with HIV infection.
The purpose of this systematic review was to identify
predictors of HIV infection available in electronic patient
records that could be incorporated in a prediction model to
identify primary care patients with undiagnosed HIV.
Candidate predictors identified are either routinely re-
corded in electronic primary care records or require
further investigation to assess if they can be reliably
identified and included in a future clinical prediction
model (Table 5).
The demographic and socio-economic predictors
identified and available in primary care records are age,
gender and deprivation quintile as a proxy for some of
the socio-economic predictors. Behavioural predictors
identified and available in electronic health records are
drug use, binge-drinking or alcohol misuse, current
smokers and obesity. All the clinical features and comorbid
diseases identified are most probably available in electronic
health records (Table 5).
Some of the demographic, socio-economic and behav-
ioural predictors identified in literature, such as ethnicity,
country of birth, income and education levels, might be
available in primary care records and therefore require
further investigation on completeness.
Limitations
This systematic review focused on studies conducted in
developed countries whereas most of the studies on HIV
predictors were conducted in developing countries,
mostly in Africa. Most of the studies conducted on HIV
were case studies, qualitative studies and cross-sectional
studies which are not suitable in identifying risk factors.
Some of the studies identified in this systematic review
reported percentages rather than odds ratio in their results
making the interpretation of risk association difficult.
Conclusion
This systematic review revealed existing scientific evidence
on predictors of HIV that can be used to inform decision
making in prognostic model development [46]. Only 2
demographic and socio-economic characteristics (age and
gender) and 4 behavioural characteristics (drugs use,
binge-drinking or alcohol misuse, current smokers and
obesity) identified in literature are available in electronic
Table 5 Predictors identified and availability in electronic primary care records (Continued)
Category of predictor Predictor of HIV infection Likelihood of being recorded in primary care records
Parotitis Likely to be present
Mononucleosis-like illness Likely to be present
Pyrexia of unknown origin Likely to be present
Hyperlipidemia Likely to be present
Hypertension Likely to be present
Diabetes Likely to be present
Sexually transmitted infection Likely to be present
Syphilis Likely to be present
Chlamydia Likely to be present
Gonorrhoea Likely to be present
Genital herpes Likely to be present
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primary-care records. The other 8 demographic and
socio-economic and 7 behavioural characteristics require
further investigation on completeness or if they are not
available at all. Further exploration will determine whether
the characteristics can be applied in a model.
Of the 51 clinical conditions in BHIVA guidelines, 18
were identified as significant predictors of HIV infection in
this systematic review. The following predictors identified
in literature are not included in the guidelines: fever/chills/
flu-like symptoms, cough, abdominal pain, minor trauma,
nausea/vomiting, rash, hyperlipidemia, hypertension and
diabetes.
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